Neu-Laxova syndrome presenting prenatally with increased nuchal translucency and cystic hygroma: The utility of exome sequencing in deciphering the diagnosis.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
05 2019
Historique:
received: 13 10 2018
revised: 18 12 2018
accepted: 21 12 2018
pubmed: 7 3 2019
medline: 22 4 2020
entrez: 7 3 2019
Statut: ppublish

Résumé

Neu-Laxova syndrome (NLS) is a lethal autosomal recessive microcephaly syndrome associated with intrauterine growth restriction (IUGR) and multiple congenital anomalies. Clinical features include central nervous system malformations, joint contractures, ichthyosis, edema, and dysmorphic facial features. Biallelic pathogenic variants in either the PHGDH or PSAT1 genes have been shown to cause NLS. Using exome sequencing, we aimed to identify the underlying genetic diagnosis in three fetuses (from one family) with prenatal skin edema, severe IUGR, micrognathia, renal anomalies, and arthrogryposis and identified a homozygous c.1A>C (p.Met1?, NM_006623.3) variant in the PHGDH gene. Loss of the translation start codon is a novel genetic mechanism for the development of NLS. Prenatal diagnosis of NLS is challenging and few reports describe the fetal pathology. Fetal neuropathologic examination revealed: delayed brain development, congenital agenesis of the corticospinal tracts, and hypoplasia of the hippocampus, cerebellum and brainstem. Each pregnancy also showed increased nuchal translucency (NT) or cystic hygroma. While NLS is rare, it may be a cause of recurrent increased NT/cystic hygroma. This finding provides further support that cystic hygroma has many different genetic causes and that exome sequencing may shed light on the underlying genetic diagnoses in this group of prenatal patients.

Identifiants

pubmed: 30838783
doi: 10.1002/ajmg.a.61076
doi:

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

813-816

Subventions

Organisme : CIHR
ID : FDN-154279
Pays : Canada
Organisme : Children's Hospital of Eastern Ontario Foundation
Pays : International
Organisme : Genome Alberta
Pays : International
Organisme : Genome British Columbia
Pays : International
Organisme : Genome Canada
Pays : International
Organisme : Genome Quebec
Pays : International
Organisme : Ontario Genomics Institute
ID : OGI-147
Pays : International
Organisme : Ontario Research Fund
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Danielle K Bourque (DK)

Regional Genetics Program, CHEO, University of Ottawa, Ottawa, Ontario, Canada.

Mireille Cloutier (M)

Regional Genetics Program, CHEO, University of Ottawa, Ottawa, Ontario, Canada.

Kristin D Kernohan (KD)

CHEO Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Eric Bareke (E)

Department of Human Genetics, McGill University, Montreal, Québec, Canada.
McGill University and Genome Quebec Innovation Centre, Montreal, Québec, Canada.

David Grynspan (D)

Department of Pathology and Laboratory Medicine, CHEO, University of Ottawa, Ottawa, Ontario, Canada.

Jean Michaud (J)

Department of Pathology and Laboratory Medicine, CHEO, University of Ottawa, Ottawa, Ontario, Canada.
CHEO Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Kym M Boycott (KM)

Regional Genetics Program, CHEO, University of Ottawa, Ottawa, Ontario, Canada.
CHEO Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH